Design and Characterization of Endostatin-Loaded Nanoparticles for In Vitro Antiangiogenesis in Squamous Cell Carcinoma

Figure 7

Swelling behaviour of drug-loaded nanoparticles. (a) Effect of varying CHT concentrations on swelling behaviour of nanoparticles. (b) Effect of varying pH conditions on the swelling behaviour nanoparticles at pH 6.8 and 7.4 resp. (c) Effect of PEI and PEG grafting on the swelling behaviour of nanoparticles.

(a)

(b)

(c)